| Accord Healthcare AG - Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66766 | | 03 | | Irinotecan Accord 300 mg/15 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01CE02 | | Irinotecan | | 24.09.2018 | | |
|
| Composition |
| irinotecani hydrochloridum trihydricum 300 mg, acidum lacticum, sorbitolum 675 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium max. 1.21 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 300mg / 15ml |
| | BAG: Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 300 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Lactic Acid | | | Sodium Hydroxide | | | Sorbitol | 675mg / 15ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 245.64 | 283.55 | A | SL | No |
|
